共 50 条
A road map for the treatment of pediatric diffuse midline glioma
被引:5
|作者:
Koschmann, Carl
[1
]
Al-Holou, Wajd N.
[1
]
Alonso, Marta M.
[2
]
Anastas, Jamie
[3
]
Bandopadhayay, Pratiti
[4
]
Barron, Tara
[5
]
Becher, Oren
[6
]
Cartaxo, Rodrigo
[1
]
Castro, Maria G.
[1
]
Chung, Chan
[7
]
Clausen, Madison
[1
]
Dang, Derek
[1
]
Doherty, Robert
[1
]
Duchatel, Ryan
[8
]
Dun, Matthew
[8
]
Filbin, Mariella
[4
]
Franson, Andrea
[1
]
Galban, Stefanie
[1
]
Moure, Marc Garcia
[2
]
Garton, Hugh
[1
]
Gowda, Pruthvi
[4
]
Marques, Joana Graca
[2
]
Hawkins, Cynthia
[9
]
Heath, Allison
[10
]
Hulleman, Esther
[11
]
Ji, Sunjong
[1
]
Jones, Chris
[12
]
Kilburn, Lindsay
[13
]
Kline, Cassie
[10
]
Koldobskiy, Michael A.
[14
]
Lim, Daniel
[1
]
Lowenstein, Pedro R.
[1
]
Lu, Q. Richard
[16
,17
]
Lum, Joanna
[1
]
Mack, Stephen
[18
]
Magge, Suresh
[1
]
Marini, Bernard
[1
]
Messinger, Dana
[1
]
Martin, Donna
[1
]
Marupudi, Neena
[1
]
Mody, Rajen
[1
]
Morgan, Meredith
[1
]
Mota, Mateus
[1
]
Muraszko, Karin
[1
]
Mueller, Sabine
[15
,19
]
Natarajan, Siva Kumar
[1
]
Nazarian, Javad
[13
,31
]
Niculcea, Michael
[1
]
Nuechterlein, Nicholas
[1
,20
]
Okada, Hideho
[1
,15
]
机构:
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Clin Univ Navarra, Navarra, Spain
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Dana Faber Canc Inst, Boston, MA 02215 USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[7] Daegu Gyeongbuk Inst Sci & Technol, Daegu 42988, South Korea
[8] Univ Newcastle, Callaghan, NSW 2308, Australia
[9] Hosp Sick Children, Toronto, ON M5G 1E8, Canada
[10] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[11] Princess Maxima Ctr, NL-3584 CS Utrecht, Netherlands
[12] Inst Canc Res, Div Mol Pathol, London SM2 5NG, England
[13] Childrens Natl Hosp, Washington, DC 20010 USA
[14] Johns Hopkins Univ, Baltimore, MD 21205 USA
[15] Univ Calif San Francisco, San Francisco, CA 94143 USA
[16] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[17] Univ Cincinnati, Cincinnati, OH 45229 USA
[18] St Jude, Memphis, TN 38105 USA
[19] Univ Zurich, Parker Inst Canc Immunotherapy, Zurich, Switzerland
[20] NIH, Bldg 10, Bethesda, MD 20892 USA
[21] Duke Univ, Durham, NC 27708 USA
[22] Advocate Childrens Hosp, Park Ridge, IL 60068 USA
[23] Weill Cornell Med, New York Presbyterian, New York, NY 10065 USA
[24] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[25] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, Dept Neurol, New York, NY 10032 USA
[26] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA
[27] Univ Colorado Denver, Denver, CO 80204 USA
[28] Univ New South Wales, Fac Med & Hlth, Sch Biomed Sci, Sydney, NSW, Australia
[29] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA
[30] Childrens Mercy, Kansas City, MO 64108 USA
[31] Univ Zurich, Zurich, Switzerland
来源:
基金:
美国国家卫生研究院;
关键词:
HIGH-GRADE;
CELLS;
GAIN;
D O I:
10.1016/j.ccell.2023.11.002
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Recent clinical trials for H3K27-altered diffuse midline gliomas (DMGs) have shown much promise. We present a consensus roadmap and identify three major barriers: (1) refinement of experimental models to include immune and brain-specific components; (2) collaboration among researchers, clinicians, and industry to integrate patient-derived data through sharing, transparency, and regulatory considerations; and (3) streamlining clinical efforts including biopsy, CNS-drug delivery, endpoint determination, and response monitoring. We highlight the importance of comprehensive collaboration to advance the understanding, diagnostics, and therapeutics for DMGs.
引用
收藏
页码:1 / 5
页数:5
相关论文